Skip to main content

View full-text article in PMC

. 2022 Nov 1;8(11):2242–2252. doi: 10.1021/acsinfecdis.2c00459

Table 2. Results of Checkerboard Assays with MRL-494 (1) and Rifampicin.

	MIC^a
	MRL-494 (1)		rifampicin
strain	alone	in combination	alone	in combination	FICI^b
E. coli ATCC 25922	16	1	2	0.13	0.125
E. coli BW25113	8	2	4	0.13	0.281
K. pneumoniae ATCC 13883	>128	2	8	0.25	≤0.039
A. baumannii ATCC 9955	32	2	1	0.06	0.125
P. aeruginosa ATCC 27853	16	4	16	0.25	0.266

^a

Minimum inhibitory concentration (μg/mL).

^b

Synergy defined as FICI ≤0.5.